FDA Inspection 1114893 — Apotex, Inc.

Apotex, Inc. — FEI 3002808376

The FDA completed an inspection of Apotex, Inc. on Nov 8, 2019 in Etobicoke. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Nov 8, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Etobicoke (Canada)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.